MEAGAN HANSEN: Open Payments
NPI 1801535836 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,906 in 112 payments from 19 companies in 2025. Trend: 2023 $34 · 2024 $773 · 2025 $1,906
Food & beverage: $1,902Education: $4
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $344 |
| Otsuka America Pharmaceutical, Inc. | 22 | $284 |
| Alkermes, Inc. | 15 | $247 |
| E.R. Squibb & Sons, L.L.C. | 12 | $234 |
| Neurocrine BioSciences, Inc. | 7 | $166 |
| ViiV Healthcare Company | 7 | $145 |
| Collegium Pharmaceutical, Inc. | 4 | $81 |
| Janssen Pharmaceuticals, Inc | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 3 | $43 |
Products named: ARISTADA, COBENFY, VRAYLAR, INGREZZA, ABILIFY ASIMTUFII, APRETUDE, MAVYRET, REXULTI.
Industry payments across MO — which companies pay providers there.
